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ABSlRACI  Baby hamster kidney (BHK)  cells were infected with Semliki Forest virus (SFV) and, 
2 h later, were treated for 4 h with 10/~M monensin. Each of the four to six flattened cisternae 
in the Golgi stack became swollen and separated from the others. Intracellular transport of the 
viral membrane proteins was almost completely inhibited, but their synthesis continued and 
they accumulated in the swollen Golgi cisternae before the monensin block. In consequence, 
these cisternae bound large numbers of viral nucteocapsids and were easily distinguished from 
other  swollen  cisternae  such  as  those  after  the  block.  These  intracellular capsid-binding 
membranes (ICBMs) were not stained by cytochemical markers for endoplasmic reticulum (ER) 
(glucose-6-phosphatase) or  trans  Golgi cisternae (thiamine pyrophosphatase, acid  phospha- 
tase)  but were labeled by Ricinus communis  agglutinin I (RCA)  in thin, frozen sections. Since 
this lectin labels only Golgi cisternae in the middle and on the trans side of the stack (Griffiths, 
G., R. Brands, B. Burke,  D. Louvard, and G. Warren, 1982, I. Cell Biol., 95:781-792),  we conclude 
that ICBMs are derived from Golgi cisternae in the middle of the stack, which we term medial 
cisternae. The overall movement of viral membrane proteins appears to be from  cis  to  trans 
Golgi cisternae (see reference above), so monensin would block movement from  medial to the 
trans  cisternae. It also blocked the trimming of the high-mannose oligosaccharides bound to 
the viral membrane proteins and their conversion to complex oligosaccharides. These functions 
presumably reside in  trans  Golgi cisternae. This is supported  by data  in  the accompanying 
paper, in which we also show that fatty acids are covalently attached to the viral membrane 
proteins in the cis  or medial  cisternae. We  suggest that the Golgi stack can  be divided into 
three  functionally distinct compartments,  each  comprising one  or  two  cisternae. The  viral 
membrane proteins, after leaving the ER, would all pass in sequence from the cis to the medial 
to the trans compartment. 
As viral membrane proteins are transported from their site of 
synthesis in the rough endoplasmic reticulum (ER) to the cell 
surface, they pass through the stacks of flattened cisternae that 
constitute the central feature of the Golgi complex (3, 5). The 
mechanism of transport and precise route taken through the 
Golgi stack are still unknown, but transport is accompanied by 
a  precise sequence  of structural  changes  in  the  transported 
protein and its attached oligosaccharides (10-12, 15, 18, 25, 31, 
34). If these changes reflect the movement of proteins from one 
part of the stack to another, it would be important to determine 
precisely where these changes occur. We would then  gain a 
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better understanding of how the Golgi stack functions. 
One  approach  which  was  very  useful  in  early  metabolic 
studies was to block the pathway with a specific inhibitor (see 
e.g.  16). The intermediate before the block accumulated and 
could then be isolated and characterized. For the intracellular 
transport pathway,  an  equivalent  inhibitor would  cause  the 
transported protein to accumulate in the membrane compart- 
ment before the block. If this membrane compartment could 
then be isolated, or at least distinguished, from other membrane 
compartments, the structural changes in the transported pro- 
teins  could  be  related  to  the  precise point  reached  on  the 
835 intracellular  transport  pathway.  Unfortunately,  most  of  the 
inhibitors of intracellular transport also inhibit protein synthe- 
sis so that no protein accumulates. There are, however, excep- 
tions,  the  most  useful  being  the  Na ÷  ionophores  of  which 
monensin is an example (26). It blocks transport at some point 
in the Golgi complex but has no significant  effect on protein 
synthesis (37,  38).  It has previously proven difficult  to locate 
the  precise  site  of the  block because  monensin  destroys the 
characteristic  morphology  of the  Golgi  stacks;  the  flattened 
cisternae become swollen and separated from each other. 
Johnson and Schlessinger (13) noted that cells infected with 
Sindbis virus and then treated with monensin contained a class 
of swollen Golgi cisternae that were covered by viral nucleo- 
capsids.  They suggested that these were intermediates on the 
transport pathway. It occurred to us that these structures were 
in fact the membrane compartment before the monensin block. 
The viral membrane proteins were accumulating there and in 
consequence the membranes bound viral nucleocapsids, a proc- 
ess that would normally occur only at the plasma membrane. 
It no longer mattered that monensin disrupted the typical Golgi 
morphology;  the  bound  nucleocapsids  clearly  distinguished 
these Golgi cisternae from others in the stack. 
Using  this fortuitous observation, we set out to identify the 
site at which monensin blocks transport. We have used Semliki 
Forest virus (SFV), a virus closely related to Sindbis, which is 
affected in a similar way by monensin (14). Using a combina- 
tion of cytochemistry, immunocytochemistry, and biochemis- 
try, we have been able to determine the site within the Golgi 
stack at which  monensin  blocks transport  of the viral mem- 
brane proteins. 
MATERIALS AND  METHODS 
Cells, Virus, and Monensin:  Baby hamster kidney (BHK)-21 cells 
and the RiCa-14 line derived from it 09) were grown and infected with SFV as 
described previously (5, 8). They were normally used 6 h after infection. 
Monensin (Eli  Lilly, Indianapolis, IN)  was stored as a  l0 mM  solution in 
absolute ethanol at -80°C for up to 3 too. It was diluted directly into the medium 
used to bathe the cells. Uninfected BHK cells were treated for 4  h with  l0 ~M 
monensin. Infected BHK cells were treated in the same way but the drug was 
added 2 h after the start of infection. 
I.abelingStudies:  Labeling  with :~S-methionine,  [aH]mannose,  and the 
preparation of labeled oligosaccharides were performed as described previously 
(5). 
Electron Microscopy:  The techniques for preparing cells for electron 
microscopy,  both  for conventional Epon  embedding and  for  frozen  section 
immunocytochemistry, including double-labehng experiments,  have been de- 
scribed previously (5, 8, 9). 
Quantitation of Double-labeling Experiments:  Thin, frozen 
sections of infected  BHK  ceils,  with  and  without  monensin treatment,  were 
labeled with anti-spike protein antibodies and Ricinus  communis  agglutinin I 
(RCA) and anti-RCA antibodies. These antibodies were then visualized using 
protein A conjugated to either 5- or 12-nm colloidal gold particles. The radius of 
a virus particle was -225 .~ (excluding the spike proteins which were normally 
not visible in frozen sections), and both sizes of gold were found within 250 A of 
the membrane of budding or budded virus. Hence, all gold particles within 500 
A  of the center of the virus were counted as labeling the viral profile. When 
groups of viral profiles were found, the total number of gold particles found 
within the overlapping 1,000-A diameter circles was averaged over the number 
of viral particles seen.  Such groups were regarded as a  single count for data 
analysis. Results were expressed as gold particles per viral profile plus-or-minus 
standard deviation of the mean. 
Cytochemistry:  For all cytochemical preparations the cells were fixed 
in 0.5% glutaraldebyde  in 100 mM PIPES, pH 7.0, containing 5% (wl/vol) sucrose 
for 30 min, washed in the same buffer containing 10% (wt/vol) sucrose, and then 
briefly washed in the buffer used for the subsequent cytochemical incubation. 
GLUCOSE 6-PHOSPHATASE;  The procedure used was a slight modification 
of that developed by Wachstein and Meisel (40). The medium was made up by 
dissolving 0.19 gm of glucose-6-phosphate (Sigma Chemical Co., St. Louis, MO) 
in l0 ml of 80 mM Tris-maleate buffer, pH 6.5, and then slowly adding 80 #1 of 
a 12% (wt/vol) solution of lead nitrate. The optimal incubation time was 120 min 
at room temperature. Control incubations were without substrate. 
T H I A M I N E  P ¥  R O P H O S P H A T A S E : This was the standard method of Novikoff 
and Goldfisher (22). To  l0 ml of 80 mM Tris-maleate buffer, pH 7.2, 9 mg of 
thiamine pyrophosphate (HCI salt; Sigma Chemical CoO was added, followed by 
50 #l of IM MnCl2 and then, slowly, 80 #l of a  12% (wt/vol) lead nitrate solution. 
Optimal incubation time was 45 min at 37°C. Control incubations were without 
substrate. 
ACID PHOSPHATASE:  The incubation medium was the same as that used 
previously (7). To 25 ml of 50 mM sodium acetate buffer, pH 5.0, 0.25 ml of 12% 
(wt/vol) lead nitrate solution was added and then, slowly, 2.5 ml of a 3% (wt/vol) 
glycerophosphate (Sigma Chemical Co.) solution. Optimal incubation time was 
45 rain at 37°C. Control incubations were either without substrate or with the 
addition of l0 mM NaF. 
NICOTINAMIDE ADENINE  DINUCLEOTIDE PHOSPHATASE:  This was as- 
sayed as described by Smith (33). The incubation mixture consisted of I-2 mM 
nicotinamide adenine dinucleotide phosphate (NADP)  (Sigma Chemical Co.), 
40 mM  sodium acetate buffer, pH  5.0,  4  mM  lead acetate, and 5% (wt/vol) 
sucrose.  Incubation  times  from  30  min  to  3  h  at  37°C  were  used.  Control 
incubations were carried out without substrate. 
Post-incuba tion Processing:  After incubation the cells, still on the 
petri dishes, were washed for 5  rain in  the  buffer used for the  cytochemical 
incubation and then briefly in 80 mM sodium cacodylate, pH 7.2, followed by 
2% (wt/vol) osmium tetroxide solution in 80 mM sodium cacodylate for 15 min 
at room temperature. Following three brief rinses in the cacodylate buffer, the 
cells were dehydrated in ethanol and the monolayer was brought off the dish 
using propylene oxide (8) and embedded in Epon 812. 
RESU LTS 
Intracellular Capsid-binding Membranes Appear 
in Infected Cells Treated with Monensin 
A  cross-section through  the peri-nuclear region of a  BHK 
cell revealed  the  typical  organization  of the  Golgi  complex. 
FIGURES 1-4  Fig.  1: Epon section of part of the perinuclear region of a BHK cell adjacent to the plasma membrane (PM). Seven 
Golgi stacks  (arrowheads) are visible in this micrograph, each comprising four to six cisternae. The ER is also apparent, often in 
close proximity to the stacks. The long arrow indicates contiguity between ER and a Golgi stack.  Between the plasma membrane 
and  the plastic layer (PI),  which  comes off  the petri  dish  with  propylene oxide, is extracellular electron-dense material often 
apparent after tannic acid treatment. This treatment also makes it difficult to see the ribosomes. (N), Nucleus. x  28,000. All bars in 
microns. Fig. 2: Epon section of part of a BHK ceil infected with Semliki Forest Virus (SFV). Two typical Golgi stacks are indicated 
(G)  as well as endoplasmic reticulum.  At the  PM  a budding virion  is indicated  (BY), as well as a complete virion  (V)  in the 
extracellular space between the plasma membrane and the plastic layer (PI). In the cytoplasm a number of capsid structures (CS) 
are apparent. These are dense, vesicular structures with many nucleocapsids (C) on their surface (see references 1, 8). The asterisks 
denote vacuoles containing bound nucleocapsids on their surface.  These are occasionally found in infected cells and resemble the 
ICBMs found  after  monensin  treatment  (see  Figs. 4 and  5).  x  47,000.  Fig. 3:  Part of the perinuclear region of a BHK cell after 
treatment with 10/LM  monensin. Large numbers of vacuoles (v)  and smaller vesicles  are evident in the region normally occupied 
by the Golgi complex. The endoplasmic reticulum  (arrowheads) appears normal  but mitochondria  (M)  are typically electron- 
dense,  x  9,100.  Fig. 4:  Part  of  the  perinuclear  region of  an  SFV-infected  BHK cell  after  treatment  with  10 /~M  monensin.  The 
asterisks  indicate typical ICBM vacuoles which are found extensively in the Golgi region of the cell. These vacuoles are covered 
with nucleocapsids on their outside and often contain budded and budding virus inside. In addition, a number of smooth vacuoles 
are evident. Mitochondria (M)  appear abnormal but ER (arrowheads) is not noticeably affected by the drug. x  25,000. 
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flattened cisternae that were slightly dilated at their rims and 
were closely apposed to each other (Fig. 1). In this, as in other 
cells  and  tissues  (13,  14,  28,  35,  37-39),  monensin  had  a 
dramatic effect on the morphology of the Golgi complex. After 
4 h  of treatment with  I0 gM monensin, the Golgi stacks were 
no longer visible. They were replaced by large vacuoles (see 
Fig. 3) which appeared to arise by extensive swelling of the 
individual  Golgi  cisternae.  Though  these  swollen  cisternae 
were  still restricted  to  a  peri-nuclear region,  they  were  no 
longer closely apposed. The morphology of other cellular struc- 
tures was largely unaltered by the presence of monensin, except 
that the mitochondrial matrices appeared to be more electron- 
dense (cf. Figs. 1 and 3). 
When BHK cells were infected with SFV and the cells were 
examined 4-6 h  later, there was no significant change in their 
overall  morphology.  The  structure  of the  Golgi  stacks,  in 
particular, was the same as in uninfected cells (cf. Figs. 1 and 
2). There were, however, two additional features. The first was 
the presence of capsid structures, first described by Acheson 
and  Tamm  (1),  but  for  which  no  function  is  known  (see 
reference 8). The second feature was the appearance of budding 
virus at the plasma membrane (Fig. 2). Cells infected with SFV 
for 2 h were then treated with monensin for 4 h. This treatment 
is  known  to  block  the  intracellular transport  of  the  SFV 
membrane proteins (14), and only rarely was virus seen to bud 
from the plasma membrane (Fig. 4; and see Fig. 25). The Golgi 
cisternae were swollen as in uninfected cells treated with mo- 
nensin, but in this case two distinct types of swollen cisternae 
could be seen (Fig. 4). The first type was smooth-surfaced and 
indistinguishable from  those seen in uninfected cells treated 
with monensin (cf. Figs. 3 and 4). The second type was covered 
by  viral  nucleocapsids,  and  completed  viral  particles  were 
frequently found inside (Fig. 4).  In many cases, it was even 
possible to  see virus budding into their interior (Fig. 5).  To 
distinguish these swollen cisteruae from those that are smooth- 
surfaced, and  because of their capsid-binding properties, we 
have chosen to call them "intracellular capsid-binding mem- 
branes" (ICBMs). 
ICBMs Contain High Concentrations  of Viral 
Membrane Proteins 
Thin,  frozen  sections of infected  BHK  cells were  labeled 
with  antibody to  the  viral membrane  proteins  followed by 
protein A-gold. We have previously shown (5) that the ER and 
Golgi  complex  membranes  are  uniformly  labeled with  this 
antibody, and an example is presented in Fig. 6.  With more 
observations,  it  has  also  become  apparent  that  there  is  a 
significant amount of smooth ER (SER) in these cells (Fig. 6) 
which is continuous with rough ER (RER) (not shown). This 
structure also labels with the antibody, as do virions budding 
at the plasma membrane,  and capsid structures, which have 
been described earlier (1,  8; and Fig. 6). After treatment with 
10/tM monensin for 4  h, the level of labeling of the plasma 
membrane  was  reduced considerably and  very few  budding 
FIGURE  5  Image of parts of two adjacent BHK cells (P, plasma membrane) at high magnification, showing four ICBMs (asterisks). 
Variable numbers of nucleocapsids (C) are seen on the outside of these vacuoles, and in the upper left corner of the micrograph 
these can be seen in face view since the section has cut the vacuole obliquely. On the inside of the ICBM are large numbers of 
budded virions, with  the spike structure apparent in many of these {e.g.,  V). 
838  THE  Iournat OF  CELL BIOLOGY. VOLUME 96, 1983 FIGURES 6and7  Fig.  6: Frozen thin section of an SFV-infected BHK cell immunolabeled with an affinity-purified antibody against 
the virus spike proteins followed by protein A-gold. Extensive labeling is seen over three Golgi stacks  (G)  as well as over smooth 
ER (SER). The labeling of  rough  ER (arrow)  is always considerably less than  that of the SER. At the plasma membrane, labeled 
budding virions (V) are indicated, x  80,000. Fig. 7: Frozen thin section of monensin-treated, SFV-infected BHK cells labeled with 
anti-spike protein antibodies. There is no significant labeling of the plasma membrane but extensive labeling of ER (arrowheads) 
and the inside of a large ICBM (asterisk).  The inset shows, at higher magnification, detail of the labeling of this ICBM. The arrow 
indicates a budding virion and the arrowhead indicates a nucleocapsid on the cytoplasmic side of the vacuole, x  42,000.  Inset, 
x  124,000. 
839 profiles were seen (Fig. 7; and see Fig. 25). The labeling of the 
whole ER appeared to be higher than that seen in untreated 
infected cells. ICBMs were heavily labeled (Fig. 7, inset),  the 
density of labeling being much higher than that seen in the 
Golgi membranes of infected cells not treated with monensin. 
Smooth-surfaced vacuoles of unknown origin were labeled, but 
the level of labeling was much less than that of ICBMs (see 
Fig. 27). 
ICBMs ARE DERIVED  FROM GOLGI CISTERNAE  IN 
THE MIDDLE OF THE STACK 
Cytochemical Studies 
GLUCOSE-6-PHOSPHATASE  (G-6-Pase):  This is a marker 
for the whole of the ER. Although there is extensive biochem- 
ical evidence showing significant G-6-Pase activity in "pure" 
isolated Golgi fractions  from  liver (20),  there  has  been  no 
convincing cytochemical demonstration of the enzyme in Golgi 
cisteruae in vivo (20, 35). It has, however, been found in the 
liver subfraction  GF3  that  is  believed to  correspond  to  cis 
Oolgi cisternae (4). 
We  consistently found  the  cytochemical reaction product 
dispersed throughout the ER of BHK ceils, before and after 
infection. The great majority of the ER in these cells is RER 
which  is  continuous  with  the  outer  nuclear  membrane.  As 
mentioned above, there is some SER whose structure is very 
distinct and is identical to that seen in liver (unpublished data). 
Both reacted uniformly for G-6-Pase. In our preparations we 
consistently found that the major part of the Golgi stack had 
no  significant amounts  of reaction product.  However,  as  is 
clear from Fig. 8, areas of reactive ER were closely apposed to 
one (and very occasionally to both) side(s) of the Golgi stack. 
Because the ribosomes on the RER are not usually visible in 
these cytochemical preparations, it is very difficult to distin- 
guish between ER,  transitional elements of the ER,  and the 
first true cis cisterua of the Golgi complex (23). Thus an image 
such as Fig. 9 might be interpreted as having reaction product 
in  the  first  (cis)  cisterua  of the  stack,  or in  the  ER  closely 
apposed to this Golgi cisterna. As we have pointed out before 
(8), one cannot easily distinguish the cis from the trans side of 
the  Golgi complex in  BHK  cells by morphological criteria 
alone. What is important for this paper is that G-6-Pase activity 
was localized in the whole ER and possibly the first cis-cistema 
but that the rest of the stack was unreactive. 
Fig. 10 shows a BHK cell treated with 10/tM monensin and 
incubated for G-6-Pase. The ER reacted under such conditions, 
but the majority of the swollen Golgi cisternae did not. How- 
ever, a few discrete elements were usually seen with significant 
deposits of reaction product. Fig. 11  shows a similar prepara- 
tion of an  SFV-infected cell treated with  monensin.  Again, 
while the ER clearly reacted uniformly, the ICBM structures 
were always free of reaction product. 
THIAMINE PYROPHOSPHATASE  (TPvase):  This is a cy- 
tochemical marker for trans Golgi cistemae (21).  In uninfected 
(Fig. 12) and infected (Fig. 13) BHK cells, as in other systems, 
one or two cisteruae on one side of the Golgi stack specifically 
reacted for TPPase. In uninfected cells treated with monensin, 
only some of the swollen cisternae in the Golgi region were 
reactive. The majority of the cisternae, and all other organelles, 
did not react (Fig. 14). This clearly shows that despite the gross 
morphological changes the cytochemical individuality of the 
swollen cisteruae was retained. When SFV-infected cells were 
treated with monensin and then reacted for TPPase, there was 
no  reaction product  in  the  ICBM  structures  (Fig.  16).  The 
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combination of SFV infection plus monensin treatment led to 
the appearance of a  morphologically distinct structure in the 
Golgi region  which  reacted  specifically and  exclusively for 
TPPase (Figs. 15 and  16). This TPPase-positive structure ap- 
peared to comprise a rigid, fenestrated lamella, so convoluted 
as to  form  an  approximately spherical shape.  In negatively 
stained frozen sections (as well as in EPOn sections, though less 
clearly) it was strikingly similar to insect septate junctions (17) 
with  bridgelike structures  being found  across each  cisterua, 
connecting the two membranes (Fig. 20). In oblique or trans- 
verse sections it was evident that these cross-bridges formed a 
periodic array (Fig. 20,  inset).  Although this structure  may 
have had sparse deposits of reaction product for G-6-Pase (Fig. 
11), they did not appear to be significant. 
ACID PHOSPHATASE  (AcPase):  This  is a  cytochemical 
marker for lysosomal structures in many different cell types. It 
has also been used as a marker for trans Golgi cisternae, usually 
the most distal cisterna that has been referred to as a  part of 
GERL  (21).  This cisterua has been shown  to be continuous 
with parts of the lysosomal system. 
In BHK cells, both before (Fig. 17) and after infection (not 
shown),  there  were variable amounts  of reaction product  in 
one  or two cisternae on  one side of the  Golgi stack. There 
appeared to be some overlap with the TPPase-reactive cisterna, 
in  that  this  cisterna  sometimes  had  small  but  significant 
amounts of reaction product. Conversely, as is apparent in Fig. 
13, the trans-most cisterna often contained significant deposits 
of lead when reacted for TPPase. The lysosomes were invari- 
ably positive for AcPase. 
In the  presence of monensin,  BHK  cells showed  reaction 
product in lysosomes. It was not possible, however, to distin- 
guish  the  latter from  any  reactive, swollen  Golgi cisternae. 
When SFV-infected cells were treated with monensin, the same 
problem was evident but there was clearly no reaction product 
in ICBM structures (Fig.  18). Figs.  18 and  19 show reaction 
product  in  lysosomes. The  reticular structure  which  always 
reacted for TPPase (Figs. 15 and  16) did not usually react for 
AcPase (Fig. 19), but occasionally some reaction product was 
seen (unpublished data). This again suggests that there is some 
overlap in the two cytochemical activities. 
NICOTINAMIDE  ADENINE  DINUCLEOTIDE  PHOSPHA- 
TASE (NADPaSe)."  Recent work by Smith (33) suggests that 
this enzyme activity might serve as a useful and specific cyto- 
chemical marker for Golgi cisternae in the middle of the stack. 
This activity was found by Smith (33) in rat incisor ameloblasts 
but  we  have  unfortunately  been  unable  to  obtain a  similar 
positive reaction using BHK cells. 
CONTROLS  FOR CYTOCHEMISTRY:  In all cases the con- 
trois were negative. 
Immunocytochemical Studies 
Thin,  frozen sections of infected  BHK  ceils were  labeled 
with RCA followed by anti-RCA antibodies and protein A- 
gold. We have previously shown (8) that this lectin labels up to 
three-quarters of the cisternae on the trans  side of the Golgi 
stack. There were always one or two unlabeled cisternae on 
the cis side. An example is shown in Fig. 21. RCA labeling of 
infected cells treated with monensin showed gold particles over 
the plasma membrane, lysosomes, ICBMs, and the character- 
istic TPPase-reactive element as shown in Fig. 22. RCA label- 
hag of the ICBMs appeared to be restricted to the membrane 
of these vacuoles and not associated with the membranes of 
the  budding or budded  viral particles. This  was  seen  more 
clearly in double-label experiments in which bound RCA and FIGURES 8-11  BHK cells reacted for G-6-Pase.  In all cases the ER reacted positively. Figs. 8 and 9 are from SFV-infected BHK cells. 
The reactive ER clearly comes into close apposition to the Golgi stack (Figs. 8 and 9, arrowheads). In Fig. 8 the arrowheads indicate 
one sheet of  ER  which  is contiguous to two widely separated Golgi stacks  (G).  It is very difficult  to distinguish unequivocally 
between reaction product in true cis  Golgi cisternae (as Fig. 9 might suggest)  and close apposition of reactive ER with the Gotgi 
stack.  The central cisternae of the Golgi stack are free of reaction product. Fig. 10: A  BHK cell treated with  10/tM  monensin. All 
except one (arrowhead) of the vacuolar structures  (V) are devoid of reaction product. Fig. 11 shows G-6-Pase  reaction product in 
an infected cell treated with monensin. The ER is reactive but the ICBM structures  (arrowheads) are not. The asterisk denotes the 
TPPase-reactive cisterna (cf.  Figs. 15 and 16) which  is essentially free of reaction product.  Fig. 8, X 36,000. Fig. 9, X 56,000. Fig. 10, 
X 22,000. Fig. 11, X 37,000. 
the spike  proteins  were distinguished  using gold particles  of 
different sizes. Virus budding from untreated infected cells was 
labeled  by  both  sizes  of gold  (Fig.  23),  whereas  the  viral 
particles  in ICBMs were mostly labeled  by that size of gold 
used to localize the spike proteins  (Figs.  24-26); that size of 
gold used to localize bound RCA was generally restricted to 
the membranes of the ICBMs (Figs. 24-26). To confirm these 
observations, we quantitated the labeling in these double-label 
GmFFItHS  er  at  Dissection of the Golgi Complex  84"1 FIGURES 12-16  BHK cells reacted for TPPase. Fig. 12 is an image of a BHK cell, showing typical reaction product in one or two 
cisternae (arrowheads) on one side of the Golgi stack. This micrograph also indicates the difficulty in seeing any clear morphological 
difference  between the two sides  of the Golgi stack.  Fig. 13 shows,  in  an SFV-infected  BHK cell, a rare  example where the ER 
adjacent to the obliquely sectioned Golgi stack (arrowhead) is free of ribosomes on the cis side of the Golgi stack,  the one or two 
cisternae  reactive  for  TPPase being  located  on  the  opposite  side.  Fig. 14  shows  TPPase reaction  product  in  two  vacuoles 
(arrowheads) in a BHK cell after treatment with 10/,tM  monensin. The other vacuoles (v) are free of reaction product. Figs. 15 and 
16 show BHK cells infected with SFV and treated with 10/~M  monensin. In  Fig. 15 the typical collapsed TPPase-positive cistema is 
shown.  Arrowheads indicate unreactive ER.  In  Fig. 16 the large arrowheads indicate parts of  the TPPase-positive element. The 
ICBM  (asterisk)  has no reaction product. The small arrows within  the ICBM indicate budding virions.  Fig. 12,  x  57,000. Fig. 13, 
x  34,000. Fig. 14, x  23,000, Fig. 15, x  34,000. Fig. 16, X 39,000. 
experiments  and  the  results are  presented  in  Table  I.  Gold 
labeling of spike proteins was essentially the same whether the 
virus was  budding from the  plasma membrane  of untreated 
cells or from the membrane of the ICBMs. In contrast, the level 
of RCA labeling of budding (or budded) virus in ICBMs was 
only one-third of that of virus budding from the cell surface. 
Furthermore,  the  RCA labeling of virus in ICBMs was to  a 
large  extent  an  unavoidable artifact of the  method  used  to 
quantitate the labeling. Since all gold particles within 500/~ of 
the virus center were counted, gold particles labeling the ICBM 
842  ]-HE IOURN^t OF  CELt BIOLOGY. VOLUME 96, 1983 FrGURES 17-19  BHK cells reacted for AcPase.  Fig. 17 shows typical reaction product in an uninfected cell.  In the Golgi complex 
region  (G),  reaction product  is found  predominantly in one cisterna  (arrowhead) on,one side of the stack. Characteristically, a 
variable amount of reaction product is found in secondary lysosomes (Ly). Figs. 18 and 19 show the same reaction in SFV-infected 
cells treated with 10 #M monensin. In Fig. 18, the ICBMs  (asterisk) are free of reaction product, whereas the Ly reacted. Similarly, 
in Fig. 19, whereas the Ly shows reaction product, the TPPase-reactive element (T) does not. Fig. 17, x  42,000.  Fig. 18 x  34,000. Fig. 
19, x  32,000. 
membrane itself were necessarily included. 
Double-labeling with RCA and anti-spike antibodies also 
allowed us to identify tentatively the cis Golgi compartment in 
infected cells treated with monensin. The cisternae comprising 
this compartment should be labeled by anti-spike antibodies 
but not by RCA,  and an example is shown in Fig. 27.  The 
level of labeling of these swollen cisternae was lower than that 
of the comparable cis cisternae in untreated cells,  and their 
number was lower than expected. The reasons for this are not 
yet understood. 
In summary, the ICBMs were labeled by a marker (RCA) 
which labels up to four cisternae on the trans side of the stack, 
but not by the cytochemical markers for the two  trans-most 
cisternae. This evidence, in addition to a negative reaction with 
G-6-Pase, which labeled ER and possibly the first cis Golgi 
cisterna, would suggest that the ICBM structures are derived 
from one or two cisternae in the middle of the Golgi stack. We 
term these the medial cisternae. 
VIRAL  MEMBRANE  PROTEINS  IN  ICBMs  ARE 
UNCLEAVED  AND  UNTRIMMED 
Labeling Studies  with  35S-Methionine 
SFV-infected BHK cells were labeled for 5 min with 35S- 
methionine  and the proteins fractionated by SDS PAGE. After 
fluorography the two viral membrane proteins (El  and p62) 
were clearly visible (Fig. 28, lane 1). If the labeled cells were 
incubated for  90  rain  in  the  presence  of excess  unlabeled 
GRIF~IrHS E, AL.  Dissection  of lhe Golgi Complex  843 FIGURE 20  Frozen thin section of the TPPase-reactive element in a monensin-treated SFV-infected BHK cell. Although this section 
had been immunolabeled for RCA binding, the gold particles are hardly visible due to the heavy contrasting with uranyl acetate. 
However, this contrasting allows one to visualize periodic septate connections between the membranes of the flattened cisternae 
(small arrowheads). When cut transversely,  this appears as a periodic array  (large arrowheads). The  inset shows this in greater 
detail. The arrows indicate the periodic repeat, x 48,000. Inset, x  148,000. 
methionine, these viral membrane proteins were transported to 
the  cell surface.  During  transport,  E1  was  converted to  the 
mature  form  of higher molecular weight  by the  addition of 
terminal sugars  (18)  and  p62  was  cleaved to  E2  (which co- 
migrates with mature El) and E3  (not visible on this gel [see 
reference 5]) (Fig. 28, lane 2). If 10/~M monensin was present 
during  the  90-min  incubation,  neither  of these  changes  oc- 
curred (Fig. 28, lane 3). Since the maturation of El is an earlier 
biochemical event than the cleavage of p62 (5, 42), this suggests 
that monensin blocks transport before the addition of complex 
oligosaccharides. 
The same experiments were carried out with a Ricin-resistant 
BHK line (RicR-14) which has <10% of the normal levels of 
N-acetylglucosaminyltransferase I  (19).  This  cell line carries 
out the initial trimming of the mannose residues but is unable 
to complete trimming and then construct complex oligosaccha- 
rides. Immediately after labeling, the E I  and p62 migrated at 
the same rate as the proteins from BHK-21 cells (Fig. 28, lane 
4); during the 90-min incubation with excess unlabeled methi- 
onine,  p62  was  cleaved to  E2  and  E3  (not visible), and the 
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mannose trimming caused the apparent molecular weight of 
El to decrease (Fig. 28, lane 5). Since this decrease, as well as 
cleavage of p62, was prevented by monensin (Fig. 28, lane 6), 
this suggests that monensin blocks before the high mannose 
oligosaccharides are trimmed. 
Oligosaccharide Studies 
To  show  directly that  the  high  marmose  oligosaccharides 
were  not  trimmed  in  the  presence  of monensin,  we  labeled 
infected BHK and RicR-14 cells for 15 min with [aH]marmose 
and  then  incubated them  for 90  rain with  excess unlabeled 
man_nose in the presence or absence of monensin. The labeled 
viral proteins were  exhaustively digested with proteinase K, 
and the resulting glycopeptides analysed by gel filtration both 
immediately and after further digestion with endoglycosidase 
H  (Endo-H). 
In  the  absence  of monensin,  the  glycopeptides obtained 
varied with the host cell (Fig. 29 a). Endo-H treatment showed 
that in BHK-21 cells the oligosaccharides had been processed 
in part to give complex oligosaccharides, while in the Ric  a- 14 FIGURES 21-22  Frozen thin sections of SFV-infected  BHK cells labeled with  RCA followed by anti-RCA antibody and protein A- 
gold. Fig. 21 shows typical labeling of two cisternae on the  trans  side of the Golgi apparatus, leaving one cisterna on the cis  side 
(cis)  completely free of label. Fig. 22 shows a cell treated with  10 #M  monensin. The characteristic TPPase-reactive element (T) 
labeled with  RCA. A  secondary lysosomelike structure  (Ly) is also labeled. Fig. 21, x  89,000.  Fig. 22, x  81,000. 
cells all of the  oligosaccharides remained  Endo-H  sensitive 
(Fig. 29 b). 
Glycopeptides obtained from cells postincubated in the pres- 
ence of monensin were of the same size regardless of whether 
the host cells were BHK-21  or RicR14 (Fig. 29c).  Treatment 
with Endo-H showed that in both cases the glycopeptides were 
of the Endo-H-sensitive, high-mannose type, and that no com- 
plex oligosac~harides had  been  constructed  (Fig.  29 d).  The 
elution  position  of the  Endo-H  released  carbohydrate  was 
compatible with removal of at most one mannose residue from 
the high-mannose oligosaccharide. The monensin block must 
therefore be before the lesion in the RicRl4 cell line, and before 
the trimming step. 
DISCUSSION 
The  data  in  this  and  the  accompanying paper  (27)  can  be 
explained most easily by assuming that the Golgi stack com- 
prises a  series of discrete compartments and that all copies of 
the viral membrane proteins must pass through each of them 
in turn. Transport between the compartments would probably 
be  mediated  by vesicles carrying the  viral proteins  (23).  A 
schematic  model  for  the  functioning  of the  Golgi  stack  is 
depicted in Fig. 30  together with a  detailed summary of the 
data. The evidence for this model is discussed below. 
Monensin Treatment of 5FV-infected  BHK Cells 
Reveals Three Morphologically Distinct 
Golgi Compartments 
In interpreting our data we assume that monensin does not 
affect the functional identity of the individual Golgi cisternae. 
It blocks transport of viral proteins between some of them, and 
this may be related to the drug-induced swelling and separation 
of the cisternae, but it does not,  for example, cause random 
membrane fusion so that normally discrete Golgi functions are 
brought together in the same membrane compartment. This is 
most  clearly seen  after  cytocbemical staining  for  G-6-Pase, 
TPPase,  or  AcPase,  or  immunocytochemical  labeling  with 
RCA. Despite conversion by monensin of the Golgi stack into 
swollen vacuoles, approximately the same percentage of these 
vacuoles was  stained or labeled as  cisternae in  the  original 
intact  Golgi stack.  Assuming  that  the  functional identity is 
retained in  the  presence  of monensin,  it is then  possible to 
distinguish three distinct Golgi compartments. Each of these 
compartments would comprise one, or at most two, adjacent 
cisternae in any Golgi stack. 
THE  cis  COMPARTMENT"  These  cisternae  do  not  react 
positively for AcPase or TPPase and their membranes do not 
label with RCA in thin frozen sections. They may be positive 
GRIFFItHS el ^t.  Dissection  of the GolgiComplex  845 FIGURES 23-26  Frozen sections of infected  BHK cells, double-labeled with  antibodies to spike proteins and  RCA.  Fig. 23 shows 
labeling of the plasma membrane of an infected cell with antibody to RCA (5 nm gold, small arrows) and of virus particles (V) with 
antibody to spike proteins (12  nm gold, large arrow).  Figs. 24-26 are of  monensin-treated cells.  ICBM structures  (asterisks)  were 
clearly labeled with both markers. In Figs. 24 and 25, anti-spike antibodies were labeled with 12 nm gold, RCA with 5 nm gold. In 
Fig. 24, a virus budded into the ICBM was labeled with five gold particles of 12 nm. Fig. 25 shows more clearly labeling of the ICBM 
compartment with both markers. The limiting membrane (ME) has capsids (C)  on the cytoplasmic side. The arrowheads indicate 
virions budded into the ICBM which are mostly free of RCA (5 nm gold) labeling but are labeled with antibody to spike proteins 
(12 nm gold). At the plasma membrane (PM), labeling is predominantly with the 5 nm gold (anti-RCA). A  budding virion, formed 
from spike proteins which  have leaked through the monensin block, is indicated  (BY). In  Fig. 26,  the labeling is reversed, RCA 
being visualized with 12 nm gold, and spike proteins with  5 nm gold. The ICBM membrane (ME) was labeled by both markers. 
Two budded virions were labeled only with 5 nm gold (small arrows). Fig. 23, x  117,000. Fig. 24, x  94,000. Fig. 25, x  100,000. Fig. 26, 
x  110,000. 
for G-6-Pase but can be distinguished from G-6-Pase reactive 
ER  since the latter is unaffected by monensin  treatment.  In 
infected ceils they contain spike proteins at low concentrations, 
even in the presence of monensin, and bind few if any nucleo- 
capsids. 
THEmediaIcoMPARTMENT:  These cistemae do not react 
positively for TPPase,  G-6-Pase, or AcPase  but  their mem- 
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branes  can  always  be  labeled with  RCA.  In  infected  cells 
treated with monensin, the SFV membrane proteins accumu- 
late  in  this  compartment,  causing  nucleocapsids to  bind  in 
large numbers.  They thus give rise to  ICBMs. The  fact that 
ICBMs do not stain for AcPase is important because it shows 
that they are not derived from the lysosomal system. 
THE trans COMPARTMENT:  This by defmition reacts pos- itively for TPPase and AcPase, and the membranes can also be 
labeled with RCA in thin, frozen sections. The TPPase-positive 
cisterna assumes a  striking fenestrated appearance in infected 
cells treated with monensin and can be identified even in the 
absence of the TPPase reaction. The reasons for this appear- 
ance,  and  the  periodic cross-bridges revealed in  thin  frozen 
sections, are unknown.  Relatively low concentrations of SFV 
membrane  proteins  are  found  in  these  membranes  in  the 
presence of monensin, and occasional nucleocapsid binding is 
seen. 
Different  Golgi Functions Are Found in 
Different Compartments 
Our data strongly suggest that monensin blocks the move- 
ment of SFV membrane proteins from the medial to the trans 
compartment. It also prevents the trimming of the high-man- 
nose  oligosaccharides bound  to  the  viral  proteins  and  the 
TABLE  I 
Quantitation of Double-labeling with RCA (AuS) and anti-SFV 
(Au12) over Budding and Budded Virus Particles * 
No. of gold particles/ 
viral profile 
Membrane  Anti-SFV  RCA 
Plasma membrane of normal infected  10.5 _+ 3.5  5.9 +  2.9 
cells 
ICBMs  8.1 +  3.4  1.9 _+ 1.5 
* 50 budded virus profiles per count. 
construction of complex oligosaccharides which  is known to 
occur within the Golgi stack (5). These Golgi functions should 
therefore be restricted to the trans Golgi compartment. This is 
consistent  with  our  previous  work  (8)  and  that  of others, 
notably the recent work by Roth and Berger (29). They showed 
that  one  of the  enzymes  responsible for the  construction of 
complex oligosaccharides, galactosyl transferase,  co-localizes 
with TPPase in trans Golgi cisternae. 
Covalent attachment of fatty acids to  the  viral membrane 
proteins was not blocked by monensin in this or in other viral 
systems (13).  It is also an  earlier event than  construction of 
complex oligosaccharides (31).  This would restrict fatty acyla- 
tion to the cis or medial compartments. This has been confirmed 
by  separating the  medial  compartments  from  the  others  on 
sucrose gradients as shown in the accompanying paper (27). 
Viral Proteins Move  from  the cis to  the medial 
to  the trans Compartments 
SFV membrane proteins appear to move from cis to trans 
Golgi cisternae (8).  In this paper we provide strong evidence 
that monensin blocks the movement  from the  medial to  the 
trans compartment.  Since almost all of the viral proteins ac- 
cumulate in the medial compartment (producing ICBMs), it is 
unlikely that  there  is movement  directly from the  cis to  the 
trans compartment. It is reasonable to conclude that proteins 
in the cis compartment must move via the medial compartment 
to reach the trans one. This argues against a transport pathway, 
proposed for secretory proteins, which allows a product leaving 
the ER in a vesicle to enter any cisterna of the Golgi stack, or 
even bypass the Golgi stack altogether (23). 
FIGURE 27  Frozen  thin section of an infected BHK cell treated with 10#M monensin and double-labeled with antibodies to spike 
protein, protein A  (12 nm)-gold  (large arrow) and RCA, anti-RCA antibodies and protein A  (5 nm)-gold  (small arrow). The ICBM 
structure (asterisk)  was labeled with both antibodies, whereas the two vacuolar structures  (V) adjacent to the nucleus were only 
labeled with anti-spike antibodies, as were the ER and nuclear envelope (NE). The large vacuole of unknown origin on the bottom 
left of the micrograph has reacted faintly with RCA (small gold) but is completely free of spike protein labeling, x  64,000. 
GrlmtHs  et AL.  Dissection  of the Golgi  Complex  847 FIGURE 28  SDS PAGE of a~S-me- 
thionine-labeled  SFV-infected 
cells.  The  cell  lines  used  were 
BHK-21  (lanes  I-3)  and  RicR-14 
(lanes  4-6).  Cells  were  labeled 
with 35S-methionine for5 min and 
harvested  immediately  (lanes  I 
and 4) or subsequently incubated 
with excess unlabeled methionine 
for 90  min  in  the absence (lanes 
2 and 5) or presence (lanes 3 and 
6) of 10/.tM monensin. 
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FIGUR[  29  The  oligosaccharides 
of  SFV  membrane  proteins  ob- 
tained from  infected  BHK-21  (0) 
or  RicR-14 (O) cells.  Fractionation 
was  done  by  gel  filtration  on  a 
Biogel P4 column.  Glycopeptides 
were prepared from infected cells 
labeled with  [3H]mannose for 15 
rain, and then incubated with ex- 
cess  unlabeled  mannose  for  90 
rain. in  the absence (a and b)  or 
presence (c and d)  of I0/IM  mo- 
nensin. The elution profiles are of 
the  glycopeptides  obtained  be- 
fore (a and c)  and after (b and d) 
Endo-H digestion. Vo =  void  vol- 
ume. 
Recycling within  the Golgi Complex 
In SFV-infected  BHK cells, RCA labels the medial and the 
trans  Golgi  compartments  (8;  and  this  paper).  The  RCA  is 
bound  to  complex  ohgosaccharides,  half  of  which  are  on 
transported viral proteins, the other half on endogenous Golgi 
components. Monensin blocks movement of the viral proteins 
to the trans compartment, where complex oligosaccharides are 
constructed.  Yet  the  resultant  ICBMs  before  the  block were 
labeled by RCA which was recognizing the complex oligosac- 
charides  on  endogenous  Golgi  components.  How  had  these 
endogenous components in the medial compartment acquired 
the complex oligosaccharides added in the trans compartment? 
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The simplest explanation is that certain Golgi proteins must be 
involved in the transport of viral proteins between the medial 
and trans compartment. They would acquire complex oligosac- 
charides in the trans compartment when ftrst synthesized and 
would  then  recycle to the  medial compartment as they carry 
out their transport function. 
Problems in the Use of Monensin as a 
General Tool 
A note of caution must be added about the use ofmonensin. 
It blocks transport of material along  a  number of pathways, 
and  the  effects  differ  depending  on  the  cell  type  and  the I 
fi6  Pose  RCA  TPPose 
+  --  _ 
AcPase  Received for publication  2 June 1982, and in revised form 3 November 
1982. 
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FIGURE 30  Schematic representation of compartments in the intra- 
cellular transport pathway and a summary of the cytochemical data 
obtained for SFV-infected BHK cells. 
transported product (2, 32, 36, 37, 39, 41).  It does not appear 
to be a specific drug, and results obtained in one system cannot 
necessarily be applied to another one. As a  specific example 
and one which contrasts with the results presented here, con- 
sider chick embryo fibroblasts infected with SFV; monensin 
appears to block transport after the viral proteins have left the 
Golgi stack but before they reach the cell surface (24).  For 
conclusions about its site of action and effects  to be valid, a 
number of different approaches must be applied to a defined 
system as we have done here. 
Another problem is the possibility of side-effects.  One that 
might invalidate our interpretation of the data would be inhi- 
bition of the  enzyme that  trims  mannose from  the  simple 
oligosaccharides,  since  the  carbohydrate  modifications  ob- 
served during transport are not required for intracellular trans- 
port (6, 30). Inhibition of this enzyme would invalidate use of 
the  carbohydrate  modifications as  a  marker  for  the  point 
reached by the transported proteins. The identification of the 
origins of the ICBMs would then rest on their labeling with 
RCA and lack of reaction for TPPase and AcPase; this would 
allow the  possibility that  ICBMs arise from fusion of post- 
Golgi vesicles.  Fortunately, this particular possibility can be 
excluded as shown in the accompanying paper (27). After 2.5- 
min  labeling with  3H-palmitate,  most  of  the  labeled  viral 
membrane proteins were  found in the  ICBM  fraction. This 
compartment is therefore temporally very close to the cis Golgi, 
where fatty acid addition probably occurs (31),  and must be 
within the  Golgi stack,  since viral membrane proteins need 
~ 15 min to cross the Golgi stack (5). 
In conclusion, we have determined the site at which monen- 
sin inhibits the transport of viral membrane proteins in SFV- 
infected BHK cells. This has allowed us to examine the path- 
way  of transport,  and  to  divide the  Golgi stack  into three 
distinct compartments. In the accompanying paper, we show 
that the unique physical properties of ICBMs can be exploited 
to distinguish them from the other Golgi compartments. 
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